BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
649 results:

  • 1. Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/emt Subtype and MMP12 Linked to the Progression and prognosis in Hepatocellular Carcinoma.
    Zuo A; Li J; Weng S; Xu H; Zhang Y; Wang L; Xing Z; Luo P; Cheng Q; Li J; Han X; Liu Z
    J Proteome Res; 2024 May; 23(5):1821-1833. PubMed ID: 38652053
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved emt in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma.
    Liu J; Li W; Lu R; Xu J; Jiang C; Duan J; Zhang L; Wang G; Chen J
    Oncol Res; 2024; 32(4):717-726. PubMed ID: 38560576
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma.
    Zhang X; Li S; Song M; Chen Y; Chang L; Liu Z; Dai H; Wang Y; Yang G; Jiang Y; Lu Y
    Oncol Res; 2024; 32(4):679-690. PubMed ID: 38560575
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long non-coding RNAFOXD1-AS1 modulated CTCs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR-615-3p.
    Guo BL; Zheng QX; Jiang YS; Zhan Y; Huang WJ; Chen ZY
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2050. PubMed ID: 38517478
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors.
    Hashemi M; Daneii P; Asadalizadeh M; Tabari K; Matinahmadi A; Bidoki SS; Motlagh YSM; Jafari AM; Ghorbani A; Dehghanpour A; Nabavi N; Tan SC; Rashidi M; Taheriazam A; Entezari M; Goharrizi MASB
    Int J Biochem Cell Biol; 2024 May; 170():106566. PubMed ID: 38513802
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial mesenchymal transition.
    Zheng Y; Li W; Huang Y; Cheng H
    Gene; 2024 Jun; 913():148374. PubMed ID: 38490505
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
    Ye Z; Li Q; Hu Y; Hu H; Xu J; Guo M; Zhang W; Lou X; Wang Y; Gao H; Jing D; Fan G; Qin Y; Zhang Y; Chen X; Chen J; Xu X; Yu X; Liu M; Ji S
    Cancer Lett; 2024 Apr; 588():216769. PubMed ID: 38438098
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
    Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
    BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
    Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
    Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
    Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
    Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
    Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal cancer liver Metastasis.
    Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
    Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
    Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
    BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
    Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
    Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Natural killer cells drive 4-1BBL positive uveal melanoma towards emt and metastatic disease.
    Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam KP; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
    J Exp Clin Cancer Res; 2024 Jan; 43(1):13. PubMed ID: 38191418
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Claudins and hepatocellular carcinoma.
    Wang W; Zhou Y; Li W; Quan C; Li Y
    Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation.
    Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
    Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
    Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
    Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. USP30 promotes the progression of breast cancer by stabilising Snail.
    Sun K; Liao S; Yao X; Yao F
    Cancer Gene Ther; 2024 Mar; 31(3):472-483. PubMed ID: 38146008
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.